I found this write up in Born2Invest that talks about NG Biotech COVID test.
https://born2invest.com/articles/ng-biotech-test-coronavirus-infection/
Interesting read - one thing that stood out is NG Biotech seem to be ready to do 6 million tests in 6 months. This coincides with AT1 plan to increase capacity of their units to 6 million by August.
Have they already signed up to sell the 6 million? NG Biotech have doubled their staff to increase capacity.
If AT1 sell 6million units to NG Biotech, then we are looking at valuation over $1/share pretty soon.
Potential SP Valuation of AT1 - 80 cents to 1.30/share, page-13
-
- There are more pages in this discussion • 1,376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
